Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00977639 · ClinicalTrials.gov registry record
Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 2
- Enrollment target
NCT00977639: Completed study, sponsored by Stanford University.
NCT00977639 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00977639 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The pathworks tissue of origin test is a microarray-based test with the goal of identifying the tissue of origin in patients with metastatic tumors of unknown primary site.
Interventions
- PROCEDURE Pathwork TOO test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00977639
The ClinicalTrials.gov registry entry for NCT00977639 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pathwork TOO test is the first listed.
NCT00977639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00977639 about?
NCT00977639 is a clinical study titled "Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies". The pathworks tissue of origin test is a microarray-based test with the goal of identifying the tissue of origin in patients with metastatic tumors of unknown primary site.
What is the current status of trial NCT00977639?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2008-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00977639?
The interventions under investigation include: Pathwork TOO test (PROCEDURE).
Who is sponsoring clinical trial NCT00977639?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.